Jianzhen Xu

3.5k total citations
53 papers, 2.5k citations indexed

About

Jianzhen Xu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jianzhen Xu has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 28 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Jianzhen Xu's work include MicroRNA in disease regulation (17 papers), RNA modifications and cancer (16 papers) and Cancer-related molecular mechanisms research (15 papers). Jianzhen Xu is often cited by papers focused on MicroRNA in disease regulation (17 papers), RNA modifications and cancer (16 papers) and Cancer-related molecular mechanisms research (15 papers). Jianzhen Xu collaborates with scholars based in China, United States and Netherlands. Jianzhen Xu's co-authors include Yongjin Li, Chi‐Wai Wong, Xing Zhao, Yujie Cai, Xiaorong Tan, Junjian Wang, Xuemei Liao, June X. Zou, Zhijian Duan and Hongjuan Jing and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Bioinformatics.

In The Last Decade

Jianzhen Xu

53 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianzhen Xu China	22	2.0k	1.2k	164	162	154	53	2.5k
Edwin Wang Canada	31	2.1k 1.0×	936 0.8×	73 0.4×	189 1.2×	267 1.7×	87	3.2k
Emily Clough United States	7	1.4k 0.7×	500 0.4×	178 1.1×	79 0.5×	208 1.4×	8	2.1k
Junfei Zhao United States	25	1.6k 0.8×	587 0.5×	91 0.6×	163 1.0×	398 2.6×	81	2.4k
Päivi Östling Finland	22	1.4k 0.7×	689 0.6×	55 0.3×	95 0.6×	361 2.3×	44	2.0k
Alexey V. Antonov United Kingdom	25	1.3k 0.7×	378 0.3×	90 0.5×	136 0.8×	384 2.5×	49	1.8k
Theresa Zhang United States	17	1.3k 0.7×	386 0.3×	143 0.9×	210 1.3×	507 3.3×	28	2.0k
Alex Adai United States	16	1.5k 0.7×	884 0.7×	54 0.3×	84 0.5×	313 2.0×	17	2.1k
Merrill Knapp United States	12	926 0.5×	578 0.5×	148 0.9×	92 0.6×	184 1.2×	19	1.5k
Bhavneet Bhinder United States	20	891 0.4×	415 0.3×	108 0.7×	66 0.4×	333 2.2×	51	1.7k
Paweł K. Mazur United States	22	1.6k 0.8×	475 0.4×	268 1.6×	95 0.6×	805 5.2×	40	2.5k

Countries citing papers authored by Jianzhen Xu

Since Specialization

Citations

This map shows the geographic impact of Jianzhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianzhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianzhen Xu more than expected).

Fields of papers citing papers by Jianzhen Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianzhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianzhen Xu. The network helps show where Jianzhen Xu may publish in the future.

Co-authorship network of co-authors of Jianzhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianzhen Xu. A scholar is included among the top collaborators of Jianzhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianzhen Xu. Jianzhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qianqian, Lihua Tang, Zhaoting Wu, et al.. (2024). Identification of transcriptionally‐active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer. Journal of Medical Virology. 96(6). e29769–e29769. 4 indexed citations

Chen, Qiuyang, et al.. (2023). Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m⁶A methylation. Cancer Science. 114(8). 3216–3229. 8 indexed citations

Zhao, Xing, et al.. (2021). TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway. Journal of Cancer. 12(16). 4883–4890. 19 indexed citations

Wang, Junjian, June X. Zou, Hong Wang, et al.. (2019). Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling. Acta Pharmacologica Sinica. 40(8). 1067–1075. 32 indexed citations

Xu, Jianzhen, Changchun Shao, Xiaojia Wang, et al.. (2019). circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death and Disease. 10(3). 175–175. 205 indexed citations

Cheng, Yinwei, Yunmei Chen, Qianqian Zhao, et al.. (2019). Long Read Single-Molecule Real-Time Sequencing Elucidates Transcriptome-Wide Heterogeneity and Complexity in Esophageal Squamous Cells. Frontiers in Genetics. 10. 915–915. 12 indexed citations

Zhao, Qianqian, et al.. (2019). OmicsARules: a R package for integration of multi-omics datasets via association rules mining. BMC Bioinformatics. 20(1). 554–554. 3 indexed citations

Zhao, Xing, Yujie Cai, & Jianzhen Xu. (2019). Circular RNAs: Biogenesis, Mechanism, and Function in Human Cancers. International Journal of Molecular Sciences. 20(16). 3926–3926. 191 indexed citations

Kaina, Bernd, Alberto Izzotti, Jianzhen Xu, et al.. (2018). Inherent and toxicant-provoked reduction in DNA repair capacity: A key mechanism for personalized risk assessment, cancer prevention and intervention, and response to therapy. International Journal of Hygiene and Environmental Health. 221(7). 993–1006. 10 indexed citations

10.

Wang, Junjian, Haibin Wang, Ling‐Yu Wang, et al.. (2016). Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy. Cell Death and Differentiation. 23(11). 1886–1896. 26 indexed citations

11.

Wang, Junjian, Peng Chen, Jianzhen Xu, et al.. (2015). Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature. PLoS ONE. 10(6). e0128229–e0128229. 10 indexed citations

12.

Wang, Chen‐Yu, et al.. (2015). miRNA-mRNA interaction network in non-small-cell lung cancer. Interdisciplinary Sciences Computational Life Sciences. 9 indexed citations

13.

Wu, Deng, Juanjuan Kang, Yan Huang, et al.. (2014). Deciphering global signal features of high-throughput array data from cancers. Molecular BioSystems. 10(6). 1549–1556. 7 indexed citations

14.

Zou, June X., Zhijian Duan, Junjian Wang, et al.. (2014). Kinesin Family Deregulation Coordinated by Bromodomain Protein ANCCA and Histone Methyltransferase MLL for Breast Cancer Cell Growth, Survival, and Tamoxifen Resistance. Molecular Cancer Research. 12(4). 539–549. 143 indexed citations

15.

Xu, Jianzhen, Dong Wang, & Wencai Ma. (2014). Cell Death in Human Health and Disease. BioMed Research International. 2014. 1–2. 5 indexed citations

16.

Xu, Jianzhen, Yanfei Wang, Xiaorong Tan, & Hongjuan Jing. (2012). MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy. 8(6). 873–882. 116 indexed citations

17.

Xu, Jianzhen & Chi‐Wai Wong. (2012). Enrichment Analysis of miRNA Targets. Methods in molecular biology. 936. 91–103. 13 indexed citations

18.

Xu, Jianzhen, Xuemei Liao, Na Lü, Wenming Liu, & Chi‐Wai Wong. (2011). Chromatin‐modifying drugs induce miRNA‐153 expression to suppress Irs‐2 in glioblastoma cell lines. International Journal of Cancer. 129(10). 2527–2531. 49 indexed citations

19.

Zhao, Liming, Ting Liang, Jianzhen Xu, et al.. (2009). Two novel FBN1 mutations associated with ectopia lentis and marfanoid habitus in two Chinese families.. PubMed. 15. 826–32. 3 indexed citations

20.

Xu, Jianzhen & Chi‐Wai Wong. (2008). A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA. 14(7). 1276–1283. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact